Legislation Details

File #: 20-10314    Version: 1 Name: 20161 COVID-19 Testing Services (Sept - Dec 2020)
Type: Agenda Item Status: Consent Agenda
File created: 8/21/2020 In control: City Council
On agenda: 9/1/2020 Final action: 9/1/2020
Title: Ratify a two week extension of the three previous COVID-19 testing agreements in the amount not to exceed $318,250; award a Price Agreement for COVID-19 Testing Services from TopCare Medical Group, Inc. (up to $600,000 monthly) for four weeks with the option to renew for four additional four-week periods totaling $3,000,000 if all extensions are exercised; and authorize the City Manager to execute the renewal options with aggregate price fluctuations of the lesser of up to $50,000 or 25% of the original maximum price so long as sufficient funding is appropriated by the City Council to satisfy the City’s obligation during the renewal terms.
Attachments: 1. 20161 - CC Exhibit.pdf, 2. 20157 - CC Exhibit.pdf

From

Angi Mize, Sr. Buyer

 

Title

Ratify a two week extension of the three previous COVID-19 testing agreements in the amount not to exceed $318,250; award a Price Agreement for COVID-19 Testing Services from TopCare Medical Group, Inc. (up to $600,000 monthly) for four weeks with the option to renew for four additional four-week periods totaling $3,000,000 if all extensions are exercised; and authorize the City Manager to execute the renewal options with aggregate price fluctuations of the lesser of up to $50,000 or 25% of the original maximum price so long as sufficient funding is appropriated by the City Council to satisfy the City’s obligation during the renewal terms.

 

Presenter

Cindy Mendez, Environmental Quality Manager

 

Recommend Action

Approve

 

Analysis

On June 16th, 2020 City Council ratified three COVID-19 testing agreements (Drive Through Testing, At Home Testing, and Rapid/Nursing Home Testing) and approved the City Manager’s Office to execute the second contract renewal(s) as part of the City’s ongoing pandemic response. On August 4, 2020 City Council ratified a contract modification to the Drive Through testing agreement switching from molecular tests to antigen test due to a backlog of tests being processed at the laboratories.

 

A ratification in necessary for a two week extensions (in the amount not to exceed $318,250) to the previous Drive Through Testing, At Home Testing, and Rapid/Nursing Home Testing agreements which were required to allow competitive bids to be received, evaluated, and recommended for award.

 

Approve the new agreement resulting from RFB# 20161 which would allow the City to continue testing services through the end of December 2020 with TopCare Medical Group, Inc. in an amount not to exceed $600,000 per each four week period, and $3,000,000 cumulatively.  Pricing is as follows:  Antigen & Molecular $225.00; Nursing Home & at home Antigen test $150.00; Nursing Home & at home Molecular test, $185.00; Drive through Antigen test, $125.00; Drive through Molecular test, $185.00.

 

Notice of RFB #20161 was advertised in the Fort Worth Star Telegram and Public Purchase; it was distributed to 30 vendors. There were no Grand Prairie vendors available for this commodity.  Four bids were received as shown on attachment A.

 

The award was based on best value criteria set up in the specification, including price, past relationship with the city and other municipalities, qualifications, references, and other relevant criteria as listed in the specification.

 

TopCare Medical Group, Inc. meets specifications and is recommended for award. 

 

Financial Consideration

Federal Funds from either The Coronavirus Aid, Relief, and Economic Security (CARES) Act or through the FEMA Public Assistance program are anticipated to be available for this expenditure.  All federal procurement guidelines were followed in the solicitation of this competitive contract.